Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study.
J Clin Oncol. 2022 Jan 1;40(1):52-62. doi: 10.1200/JCO.21.00838. Epub 2021 Oct 4.
J Clin Oncol. 2022.
PMID: 34606378
Free PMC article.
Clinical Trial.
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.
Noy A, de Vos S, Coleman M, Martin P, Flowers CR, Thieblemont C, Morschhauser F, Collins GP, Ma S, Peles S, Smith SD, Barrientos JC, Chong E, Wu S, Cheung LW, Kwei K, Hauns B, Arango-Hisijara I, Chen R.
Noy A, et al. Among authors: arango hisijara i.
Blood Adv. 2020 Nov 24;4(22):5773-5784. doi: 10.1182/bloodadvances.2020003121.
Blood Adv. 2020.
PMID: 33227125
Free PMC article.
Clinical Trial.
Item in Clipboard
Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III InnovateTM Trial.
Trotman J, Buske C, Tedeschi A, Matous JV, MacDonald D, Tam CS, Tournilhac O, Ma S, Treon SP, Oriol A, Ping J, Briso EM, Arango-Hisijara I, Dimopoulos MA.
Trotman J, et al. Among authors: arango hisijara i.
Clin Cancer Res. 2021 Nov 1;27(21):5793-5800. doi: 10.1158/1078-0432.CCR-21-1497. Epub 2021 Aug 11.
Clin Cancer Res. 2021.
PMID: 34380643
Free PMC article.
Clinical Trial.
Item in Clipboard
Item in Clipboard
Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma.
Siddiqi T, Coutre S, McKinney M, Barr PM, Rogers K, Mokatrin A, Valentino R, Szoke A, Deshpande S, Zhu A, Arango-Hisijara I, Osei-Bonsu K, Wang M, O'Brien S.
Siddiqi T, et al. Among authors: arango hisijara i.
Leuk Lymphoma. 2022 Jul;63(7):1580-1588. doi: 10.1080/10428194.2022.2038372. Epub 2022 Feb 28.
Leuk Lymphoma. 2022.
PMID: 35227147
Clinical Trial.
Item in Clipboard
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function.
Abdelmagid SM, Barbe MF, Rico MC, Salihoglu S, Arango-Hisijara I, Selim AH, Anderson MG, Owen TA, Popoff SN, Safadi FF.
Abdelmagid SM, et al. Among authors: arango hisijara i.
Exp Cell Res. 2008 Aug 1;314(13):2334-51. doi: 10.1016/j.yexcr.2008.02.006. Epub 2008 Mar 10.
Exp Cell Res. 2008.
PMID: 18555216
Item in Clipboard
Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF-beta1-induced extracellular matrix production in osteoblasts.
Arnott JA, Nuglozeh E, Rico MC, Arango-Hisijara I, Odgren PR, Safadi FF, Popoff SN.
Arnott JA, et al. Among authors: arango hisijara i.
J Cell Physiol. 2007 Mar;210(3):843-52. doi: 10.1002/jcp.20917.
J Cell Physiol. 2007.
PMID: 17133352
Item in Clipboard
Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
Abdelmagid SM, Barbe MF, Arango-Hisijara I, Owen TA, Popoff SN, Safadi FF.
Abdelmagid SM, et al. Among authors: arango hisijara i.
J Cell Physiol. 2007 Jan;210(1):26-37. doi: 10.1002/jcp.20841.
J Cell Physiol. 2007.
PMID: 17034042
Item in Clipboard
Cite
Cite